Plasma FGF21 Levels Are Not Associated with Weight Loss or Improvements in Metabolic Health Markers upon 12 Weeks of Energy Restriction: Secondary Analysis of an RCT

Recent studies suggest that circulating fibroblast growth factor 21 (FGF21) may be a marker of metabolic health status. We performed a secondary analysis of a 12-week randomized controlled trial to investigate the effects of two energy restriction (ER) diets on fasting and postprandial plasma FGF21...

Descripción completa

Detalles Bibliográficos
Autores principales: Gijbels, Anouk, Schutte, Sophie, Esser, Diederik, Michielsen, Charlotte C. J. R., Siebelink, Els, Mars, Monica, Mensink, Marco, Afman, Lydia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735516/
https://www.ncbi.nlm.nih.gov/pubmed/36501091
http://dx.doi.org/10.3390/nu14235061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735516/
https://www.ncbi.nlm.nih.gov/pubmed/36501091
http://dx.doi.org/10.3390/nu14235061

Ejemplares similares